Sun Pharma share price has seen a 10% decline in year-to-date (YTD) performance and an 11% drop over the past six months.

Sun Pharmaceutical Industries Ltd. closed 9.70% below its 52-week high of 1,960.20 rupees, which the company reached on ...

Donald Trump has announced reciprocal tariffs on about 60 countries, including India. He announced 27 per cent reciprocal ...

Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 8,053 calls trading, 1.0x expected, and implied vol increasing over 21 ...

Sun Pharmaceutical Industries Ltd. closed 12.55% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Emrosi™ approved by FDA for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway; initial distribution ...